Sarilumab

Kevzara

200 MG / 1.14 ML SolutionCanadaMarketedAuthorised 8 Feb 2017

In other countries

The same active substances on other registers, the same brand first.

Kevzara 150 MG Solucion Inyectable en Pluma PrecargadaSpain · 150 mg · solución inyectable · Sanofi Winthrop IndustrieSame brand
Kevzara 200 MG Solucion Inyectable en Jeringa PrecargadaSpain · 200 mg · solución inyectable · Sanofi Winthrop IndustrieSame brand
Kevzara 200 MG Solucion Inyectable en Pluma PrecargadaSpain · 200 mg · solución inyectable en pluma precargada · Sanofi Winthrop IndustrieSame brand
KevzaraEuropean Union · Sanofi Winthrop IndustrieSame brand
KevzaraCroatiaSame brand
KevzaraItaly · Soluzione iniettabile in penna pre-riempita · Sanofi Winthrop IndustrieSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sarilumab

Kevzara

200 MG / 1.14 ML SolutionCanadaMarketedAuthorised 8 Feb 2017

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Kevzara 150 mg, oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · Sanofi Winthrop Industrie

Kevzara 150 mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Sanofi Winthrop Industrie

Kevzara 175 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Sanofi Winthrop Industrie

Kevzara 150MG Sol. for Inj. in Pre - Filled PenSaudi Arabia · Sanofi Winthrop Industrie

Kevzara 150MG Sol. for Inj. in Pre-Filled SyringeSaudi Arabia · Sanofi Winthrop Industrie

Kevzara 200MG Sol. for Inj. in Pre - Filled PenSaudi Arabia · Sanofi Winthrop Industrie

KevzaraUnited States · 150MG/1.14ML, 200MG/1.14ML · injectable · Sanofi Synthelabo

KevzaraUnited States · 150MG/1.14ML · Injection · Sanofi-Aventis U.S. LLC

KevzaraUnited States · 200MG/1.14ML · Injection · Sanofi-Aventis U.S. LLC

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sarilumab
Strength: 200 MG / 1.14 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 8 Feb 2017
Registration: DIN 02460548
Marketing authorisation holder: Sanofi-Aventis Canada INC
ATC code: L04AC14
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D

Health Canada

KevzaraSarilumab · 150 MG / 1.14 ML · SolutionCanadaCancelled